Welcome to episode 6 of Let’s Talk Quality.
I was joined by Greg Whitehead. Greg is Head of Quality at Editas Medicine and has been working in biotech for 30 years, with a particular focus on cell and gene therapy.
Greg has a vision to leave the quality assurance industry in a better place than when he started in the industry. We spoke about why this is important to him and what he is doing to help bring this vision to life. We spoke about the following:
- How not many people set out to have a career in quality assurance, and why this is
- a benefit to the industry.
- As Greg grew in his career, why he began thinking about what he’s leaving behind in the QA industry.
- How to relationships with regulatory bodies and health authorities have evolved over the years.
- Greg’s advice for inexperienced QA professional in how to work well with the FDA.
- What makes a truly talented quality assurance leader in biotech.
- Embedding quality as a culture and mindset in the industry.
- Finding the balance when building quality functions.
- The legacy Greg wants to leave behind him.
Greg has a huge passion for the quality assurance industry and developing leaders that can help move the industry forward. He has achieved a lot in his career so far, and will continue to add value to the wider industry. I’m looking forward to seeing Greg and the team at Editas develop their gene therapies as they move closer to bringing them to commercial use.
Greg was an inspiration to speak with, and I’d urge any QA professional looking to develop their leadership career to listen and reach out to Greg!
I hope you enjoy the show!